Entasis Therapeutics Holdings Inc (ETTX) Stock Balance Sheet
USA - NASDAQ:ETTX - US2936141033 - Common Stock
2.19
-0.01 (-0.45%)
| MRQ (2022-3-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | null | null | null | null | null | |||
| Cash Equivalents | 33.55M | 32.31M | 53.25M | 16.03M | 49.36M | |||
| Cash Due From Banks | null | null | null | null | null | |||
| Investments | null | null | null | null | null | |||
| Net Loans | null | null | null | null | null | |||
| Insurance Receivables | null | null | null | null | null | |||
| Marketable Securities | null | null | null | 24.96M | 35.73M | |||
| Receivables | 1.15M | 1.26M | 1.89M | 1.23M | 1.71M | |||
| Inventories | null | null | null | null | null | |||
| Other Current Assets | 5.19M | 6.25M | 5.00M | 6.78M | 1.99M | |||
| Total Current Assets | 39.88M | 39.81M | 60.13M | 49.01M | 88.79M | |||
| Non-Current Assets | ||||||||
| PPE Net | 3.91M | 800.00K | 1.36M | 1.97M | 420.00K | |||
| Investments And Advances | null | null | null | null | null | |||
| Goodwill | null | null | null | null | null | |||
| Intangibles | null | null | null | null | null | |||
| Other Non-Current Assets | 300.00K | 300.00K | 60.00K | 60.00K | 60.00K | |||
| Total Non-Current Assets | 4.21M | 1.11M | 1.43M | 2.02M | 480.00K | |||
| TOTAL ASSETS | 44.09M | 40.92M | 61.56M | 51.03M | 89.27M | |||
| LIABILITIES | ||||||||
| Total Deposits | null | null | null | null | null | |||
| Current Liabilities | ||||||||
| Short Term Borrowings | null | null | null | null | null | |||
| Short Term Debt | 15.01M | 0 | 0 | 0 | 0 | |||
| Current Portion Of LT Debt. | null | null | null | null | null | |||
| Accrued Expenses | 7.35M | 8.53M | 7.91M | 6.25M | 4.85M | |||
| Accounts Payable | 1.78M | 1.18M | 660.00K | 1.30M | 1.37M | |||
| Other Current Liabilities | null | null | null | null | null | |||
| Total Current Liabilities | 24.14M | 9.71M | 8.57M | 7.56M | 6.22M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0 | 0 | 0 | 0 | 0 | |||
| Deferred Taxes/Income | null | null | null | null | null | |||
| Other Non-Current Liabilities | 3.30M | 0 | 700.00K | 1.32M | 180.00K | |||
| Total Non-Current Liabilities | 3.30M | 0 | 700.00K | 1.32M | 170.00K | |||
| TOTAL LIABILITIES | 27.44M | 9.71M | 9.27M | 8.88M | 6.39M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -246.86M | -231.60M | -184.46M | -133.96M | -90.11M | |||
| Additional Paid In Capital | 263.46M | 262.76M | 236.71M | 176.10M | 172.99M | |||
| Minority Interest | null | null | null | null | null | |||
| Common Shares | 50.00K | 50.00K | 40.00K | 10.00K | 10.00K | |||
| Treasury Stock | null | null | null | null | null | |||
| Other Shareholders' Equity | null | 31.21M | null | 0 | -10.00K | |||
| Shares Outstanding | 47.85M | 47.85M | 36.64M | 13.29M | 13.12M | |||
| Tangible Book Value per Share | 0.34789 | 0.65226 | 1.4271 | 3.1723 | 6.3171 | |||
| Total Shareholders' Equity | 16.65M | 31.21M | 52.29M | 42.16M | 82.88M | |||
| TOTAL LIABILITIES AND EQUITY | 44.09M | 40.92M | 61.56M | 51.03M | 89.27M | |||
| Statistics | ||||||||
| Current Ratio | 1.65 | 4.10 | 7.02 | 6.48 | 14.27 | |||
| Return On Assets (ROA) | -117.26% | -115.20% | -82.03% | -85.93% | -36.91% | |||
| Return On Equity (ROE) | -310.51% | -151.04% | -96.58% | -104.01% | -39.76% | |||
All data in USD , ROIC based on taxRate of 0.21